Tadalafil Lilly

Medicinal product

(Invented) name

Tadalafil Lilly

Active substance (s)

Tadalafilis

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BE08, Tadalafil

Marketing authorisation holder

Eli Lilly Nederland B.V., Nyderlandai

Date of authorisation

2017-03-22

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Tadalafilis	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68061	82623	1082623	lizdinė plokštelė	N2		Receptinis	EU/1/17/1177/006	Netiekiama	-	-	No	-	-
68062	82624	1082624	lizdinė plokštelė	N4		Receptinis	EU/1/17/1177/007	Netiekiama	-	-	No	-	-
68063	82625	1082625	lizdinė plokštelė	N8		Receptinis	EU/1/17/1177/008	Netiekiama	-	-	No	-	-
68064	82626	1082626	lizdinė plokštelė	N12		Receptinis	EU/1/17/1177/009	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-03-22	Registruotas